SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (13098)1/8/1998 5:03:00 PM
From: Andrew H  Read Replies (1) | Respond to of 32384
 
Beat me to it by a couple of minutes, Henry. Very encouraging.

A couple of questions. Do you think we are talking about CTCL here? Also have you heard of targretin causing cateracts in rats?

BTW, could you briefly list the most common side effects of Targretin and Panretin and perhaps comment briefly on them? Thanks



To: Henry Niman who wrote (13098)1/8/1998 10:18:00 PM
From: squetch  Respond to of 32384
 
Thanks Henry. Wow that is an endorsement. Hope she continues to improve. Virtuall no side effects is neat, but wonder if it is just in relation to her disease. It appears to be the gel version?? The info on triglycerides seems good too. Did we figure out where her doc was?

Here is a link I found while trying to figure out what mycopia is. It may be of interest to some. africa-za.com squetch


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News